da

1163 compounds associated with depression that can be used for high-throughput and high-content screening

3500 compounds from marketed drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 325 kinase inhibitors/regulators for specific targeting of kinases, ready for high-throughput screening and high-content screening.

A unique collection of 2073 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS);

1264 small molecule compounds with pro-oxidant or anti-oxidant activity for high-throughput and high-content screening.

Oxidative stress reflects an imbalance between the systemic manifestation of reactive oxygen species (ROS) and a biological system's ability to readily detoxify the reactive intermediates or repair the resulting damage. Disturbances in the normal redox state of cells can cause toxic effects through the production of peroxides and free radicals that damage all components of the cell, including proteins, lipids, and DNA. In humans, oxidative stress is thought to be involved in the development of atherosclerosis, heart failure, myocardial infarction, cancer, infection etc. Antioxidants are a class of compounds that counteract oxidative stress and reduce oxidative damage. The TargetMol Antioxidant Compound Library is a unique collection of 2010 small molecules with inhibitory effects on oxidative stress and is a useful tool for high-throughput screening and high-content screening in the study of oxidative stress.

A unique collection of 1440 DNA Damage & Repair related compounds for high throughput screening (HTS) and high content screening (HCS);

609 non-steroidal anti-inflammatory compounds for high-throughput and high-content screening.

A unique collection of 3170 approved drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 3660 drugs with anti-cancer activity or potential anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 718 compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS).

A collection of 19730 small molecule compounds with validated activity for high throughput screening (HTS), high content screening (HCS), cell induction, and target identification;

A unique collection of 535 antifungal compounds effective for drug repurposing screening, combination screening and biological investigation.

A unique collection of 1639 compounds from food as medicine for high throughput and high content screening;

460 food additives;

A unique collection of 2120 neurotransmitter receptor compounds, can be used for HTS and HCS screening;

A unique collection of 1920 approved anti-cancer drugs for high throughput screening (HTS) and high content screening (HCS);

97 Chemotherapeutic drugs that can be used for high-throughput and high-content screening.

A unique collection of 2508 pancreatic cancer related compounds can be used in HTS and HCS;

A unique collection of 1120 bioactive small molecules with neuroprotective relevance for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 701 preclinical compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 700 histone modification related compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 530 JAK/STAT signaling targeted compounds for high throughput and high content screening;

A unique collection of 1120 compounds targeting NF-κB signaling for high throughput screening and high content screening;